GGrantIndex
← Leaderboards

Frederick R Haselton

Vanderbilt University

$7,154,000
Attributed
$13,534,379
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$13,534,379 · 11

By mechanism

R01$6,276,586 · 3
R42$2,845,149 · 1
R21$2,668,031 · 6
D43$1,744,613 · 1

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Diagnostic

Research focus

DiagnosticBaseTechnologyDesignDetectionSensitivity And SpecificityLaboratoriesResourcesReactionSamplingReagentDiagnosisUniversitiesOpticsImageSiteMethodologyMonitorSurfacePerformanceClinicSpecificityPreparationEnvironment

Grant awards (37)

Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions$762,178
R01 · FY2024 · AI · contact PI
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions$774,217
R01 · FY2023 · AI · contact PI
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions$777,138
R01 · FY2022 · AI · contact PI
Urine TB diagnostic by amplicon reconstruction for PCR detection of DNA fragments$194,296
R21 · FY2022 · AI · contact PI
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions$788,805
R01 · FY2021 · AI · contact PI
A 100-fold more sensitive TB diagnostic based on magnetic concentration and "coffee ring" formation$315,226
R01 · FY2021 · AI · contact PI
Development of RT-OLA-PCR assays for HIV drug resistance testing at Nigerian antenatal clinics$237,438
R21 · FY2021 · AI · contact PI
Urine TB diagnostic by amplicon reconstruction for PCR detection of DNA fragments$233,816
R21 · FY2021 · AI · contact PI
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions$791,662
R01 · FY2020 · AI · contact PI
A 100-fold more sensitive TB diagnostic based on magnetic concentration and "coffee ring" formation$322,883
R01 · FY2020 · AI · contact PI
Development of RT-OLA-PCR assays for HIV drug resistance testing at Nigerian antenatal clinics$197,500
R21 · FY2020 · AI · contact PI
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents$398,573
R42 · FY2019 · HG
A 100-fold more sensitive TB diagnostic based on magnetic concentration and "coffee ring" formation$326,664
R01 · FY2019 · AI · contact PI
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents$886,669
R42 · FY2018 · HG
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents$394,585
R42 · FY2018 · HG
A 100-fold more sensitive TB diagnostic based on magnetic concentration and "coffee ring" formation$329,992
R01 · FY2018 · AI · contact PI
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents$878,071
R42 · FY2017 · HG
A 100-fold more sensitive TB diagnostic based on magnetic concentration and "coffee ring" formation$370,425
R01 · FY2017 · AI · contact PI
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents$287,251
R42 · FY2017 · HG
Vanderbilt-Zambia Network for Innovation in Global Health Technologies$338,289
D43 · FY2016 · TW
Vanderbilt-Zambia Network for Innovation in Global Health Technologies$338,289
D43 · FY2015 · TW
Vanderbilt-Zambia Network for Innovation in Global Health Technologies$338,289
D43 · FY2014 · TW
Vanderbilt-Zambia Network for Innovation in Global Health Technologies$50,000
D43 · FY2014 · TW
Vanderbilt-Zambia Network for Innovation in Global Health Technologies$331,259
D43 · FY2013 · TW
Vanderbilt-Zambia Network for Innovation in Global Health Technologies$348,487
D43 · FY2012 · TW
Retinal Imaging of Prognostic Indicators of Atherosclerosis$191,875
R21 · FY2010 · HL · contact PI
Development of DNA Logic Operations for Viral Diagnostics$184,501
R21 · FY2010 · EB · contact PI
Retinal Imaging of Prognostic Indicators of Atherosclerosis$230,250
R21 · FY2009 · HL · contact PI
Development of DNA Logic Operations for Viral Diagnostics$211,525
R21 · FY2009 · EB · contact PI
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo$191,875
R21 · FY2009 · EY · contact PI
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo$188,038
R21 · FY2008 · EY · contact PI
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo$191,667
R21 · FY2007 · EY · contact PI
Lagrangian detection of biomolecular interactions$188,750
R21 · FY2005 · EB
Lagrangian detection of biomolecular interactions$226,500
R21 · FY2004 · EB
Retinal blood barrier permeability using optical tracers$226,500
R01 · FY2004 · EY
Retinal blood barrier permeability using optical tracers$226,500
R01 · FY2003 · EY
Retinal blood barrier permeability using optical tracers$264,396
R01 · FY2002 · EY